The Leadership Team at GentiBio plays a crucial role in steering the company's strategic direction and overseeing its research and development operations. Comprising co-founders and key scientific leaders, the team is dedicated to advancing the innovative development of engineered regulatory T cells (EngTregs) and ensuring the integration of cutting-edge technologies to effectively address autoimmune and inflammatory diseases. Their collective expertise drives the company's vision of restoring immune tolerance and overcoming challenges in current therapeutic approaches.